Search company, investor...

Founded Year



Series D | Alive

Total Raised


Last Raised

$23.29M | 10 mos ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+20 points in the past 30 days

About Prognos Health

Prognos Health provides a healthcare analytics platform. The platform stores and processes clinical lab test data to help pharma, payers, and diagnostics companies predict disease to drive earlier intervention. The company was founded in 2010 and is based in New York, New York.

Headquarters Location

85 Broad Street 30th Floor

New York, New York, 10004,

United States




Research containing Prognos Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Prognos Health in 1 CB Insights research brief, most recently on Jul 7, 2021.

Expert Collections containing Prognos Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Prognos Health is included in 2 Expert Collections, including Value-Based Care & Population Health.


Value-Based Care & Population Health

1,083 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Prognos Health Patents

Prognos Health has filed 1 patent.

The 3 most popular patent topics include:

  • data management
  • database management systems
  • electronic health records
patents chart

Application Date

Grant Date


Related Topics



Health informatics, Data management, Electronic health records, Database management systems, Telehealth


Application Date


Grant Date


Related Topics

Health informatics, Data management, Electronic health records, Database management systems, Telehealth



Latest Prognos Health News

Unprecedented Access to Cancer Diagnostics Data with the Launch of Prognos Oncology

Feb 7, 2024

News Provided By Share This Article Prognos Health, the most-trusted provider of real-world data, today announced the launch of Prognos Oncology. The launch of Prognos Oncology marks a pivotal moment in our mission to unlock the power of data for better health outcomes.” — Sundeep Bhan, CEO, Prognos Health NEW YORK, NEW YORK, UNITED STATES, February 7, 2024 / / -- Prognos Health , the most-trusted provider of real-world data, today announced the launch of Prognos Oncology, a real-world data product dedicated to revolutionizing cancer care by delivering unparalleled access to harmonized, multi-source oncology data. This powerful platform empowers pharmaceutical companies to achieve excellence in commercial launch planning and activation, ultimately expediting access to life-saving therapies for patients in need. Prognos Oncology connects an extensive network of data providers, and when combined with Prognos' proprietary data harmonization and enrichment process, offers unique advantages: - New partnerships and data coming to market: With the top three national labs on Datavant token and the largest Liquid Biopsy (LB) and Comprehensive Genomic Profiling (CGP) testing lab in the US. - Exclusive access: To healthcare professionals and patients only available through Prognos. - Diverse oncology genomics data: National coverage in academic and community-based settings, tissue type (liquid and solid tissue), and testing platforms (NGS, IHC, PCR, FISH, and more). - Transparency of sources: Includes testing from all major NGS testing labs and grows organically as new labs are added. - Comprehensive Genomic Profiling (CGP): Covers tumor types (tissue and liquid biopsy) and oncology-related routine testing. This combination of data breadth, depth, and harmonization empowers Prognos Oncology to deliver actionable insights and solutions for life sciences and pharmaceutical customers. Commercial teams will be empowered to leverage Prognos’ Precision Marketing suite to pinpoint high-value prescribers, gain deep patient insights, and inform targeted launch strategies based on emerging trends. This will ultimately shorten the time it takes for patients to receive potentially life-saving treatment. "The launch of Prognos Oncology marks a pivotal moment in our mission to unlock the power of data for better health outcomes. By dedicating our resources to the specific needs of the oncology space, we're amplifying our impact like never before. Armed with harmonized, multi-source data, we can empower life sciences and pharmaceutical companies to navigate the complexities of cancer care. This means faster and more targeted therapies reaching patients sooner, ultimately giving them a fighting chance in the face of formidable disease,” said Sundeep Bhan, CEO of Prognos Health. “Prognos Oncology is a cornerstone of our commitment to a future where data-driven insights translate into real hope for those battling cancer." About Prognos Health Prognos Health is a trusted provider of actionable real-world data (RWD) in the life sciences industry that is driven by its mission to unlock the power of data to improve health. Prognos Health’s exclusive, unique datasets unlock valuable insights in complex clinical populations across the entire commercial lifecycle, going beyond traditional RWD offerings. Prognos helps life sciences companies accelerate the development and delivery of innovative therapies and improve health outcomes by offering fully integrated and harmonized lab and health records on more than 325 million de-identified patients. Ashley Triscuit

Prognos Health Frequently Asked Questions (FAQ)

  • When was Prognos Health founded?

    Prognos Health was founded in 2010.

  • Where is Prognos Health's headquarters?

    Prognos Health's headquarters is located at 85 Broad Street, New York.

  • What is Prognos Health's latest funding round?

    Prognos Health's latest funding round is Series D.

  • How much did Prognos Health raise?

    Prognos Health raised a total of $58.79M.

  • Who are the investors of Prognos Health?

    Investors of Prognos Health include Safeguard Scientifics, Merck Global Health Innovation Fund, Cigna Ventures, Hikma Ventures, Maywic Select Investments and 11 more.

  • Who are Prognos Health's competitors?

    Competitors of Prognos Health include Plenful and 3 more.


Compare Prognos Health to Competitors

Verato Logo

Verato provides software-as-a-service solutions. The company offers data management, identity analytics, integrations, and more. It serves healthcare providers, government, health information exchange, and other sectors. It was formerly known as Araxid. The company was founded in 2012 and is based in McLean, Virginia.

Verily Logo

Verily operates as a precision health company in the healthcare and technology sectors. The company offers solutions that accelerate clinical research and enable more personalized care, leveraging data science, artificial intelligence, and cloud-based analytics. Its services are primarily utilized in the healthcare industry. It was formerly known as Google Life Sciences. It was founded in 2015 and is based in South San Francisco, California.

Clearwave Logo

Clearwave is a company that focuses on patient revenue and operates in the healthcare technology sector. The company offers a comprehensive patient revenue platform that includes services such as patient scheduling, registration, insurance eligibility verification, and patient communications. These services aim to improve patient engagement, streamline administrative tasks, and boost the revenue of healthcare practices. It was founded in 2004 and is based in Atlanta, Georgia.

Lifelink Systems Logo
Lifelink Systems

Lifelink Systems is a technology company focused on the healthcare sector. The company offers a conversational patient engagement platform that automates patient interactions before, during, and after healthcare visits, improving operational efficiency and customer satisfaction. Lifelink Systems primarily serves healthcare systems and life sciences companies. It was founded in 2015 and is based in San Francisco, California.


AdviNow is a company that focuses on healthcare technology. The company offers solutions that streamline patient encounters in clinics, using technology to reduce inefficiencies and improve workflow. These solutions include a mobile-first platform that supports various visit types and integrates with existing electronic medical record systems. It was founded in 2016 and is based in Scottsdale, Arizona.


Cedar is a patient payment and engagement platform. It enables health systems and medical practices across the country to elevate the patient experience beyond clinical care. Its platform leverages advanced data science, machine learning, and smart segmentation to deliver modern, consumer-friendly ways for patients. It was founded in 2016 and is based in New York, New York.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.